| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
TSE:DTOL
D2L
|
Jul 13, 2026 | BUY |
Strong Buy
+38.9% avg upside
7 analysts
|
$15.00
45.41% Upside
|
· |
|
TSE:DHT.UN
DRI Healthcare
|
Jul 13, 2026 | BUY |
Strong Buy
+11.6% avg upside
6 analysts
|
$21.00
16.11% Upside
|
· |
|
TSE:APTX
Apotex Health Corp.
|
Jul 07, 2026 | BUY |
Strong Buy
+3.7% avg upside
10 analysts
|
$40.00
5.34% Upside
|
· |
|
TSE:MDA
MDA Space Ltd
|
Jun 25, 2026 | BUY |
Buy
+32.5% avg upside
18 analysts
|
$67.00
40.52% Upside
|
· |
|
TSE:ENGH
Enghouse Systems
|
Jun 11, 2026 | HOLD |
Hold
+104.7% avg upside
6 analysts
|
$17.00
5.03% Upside
|
· |
|
TSE:WELL
WELL Health Technologies Corp
|
Jun 03, 2026 | BUY |
Strong Buy
+62.8% avg upside
11 analysts
|
$6.00
42.59% Upside
|
· |
|
TSE:CMG
Computer Modelling
|
May 25, 2026 | HOLD |
Hold
+116.2% avg upside
10 analysts
|
$5.00
33.36% Upside
|
· |
|
TSE:DND
Dye & Durham
|
May 20, 2026 | HOLD |
Strong Buy
+718.7% avg upside
7 analysts
|
$4.00
210.07% Upside
|
· |
|
TSE:KSI
kneat.com
|
May 13, 2026 | BUY |
Strong Buy
-8.9% avg upside
8 analysts
|
$6.25
3.28% Downside
|
· |
|
TSE:DCBO
Docebo
|
May 11, 2026 | BUY |
Strong Buy
+83.5% avg upside
15 analysts
|
$39.60
54.74% Upside
|
· |
|
TSE:AIF
Altus Group
|
May 08, 2026 | HOLD |
Buy
+22.5% avg upside
10 analysts
|
$51.00
12.98% Upside
|
· |
|
TSE:FSV
FirstService
|
Apr 24, 2026 | BUY |
Strong Buy
+26.4% avg upside
15 analysts
|
$288.51
41.59% Upside
|
· |
|
TSE:CIGI
Colliers International Group
|
Feb 17, 2026 | BUY |
Strong Buy
+56.4% avg upside
16 analysts
|
$244.67
82.92% Upside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.